Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page
- Check2 days agoChange DetectedA new revision entry (v3.3.4) was added to the history and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.3 was added to the record history and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These updates affect metadata and footer content rather than study details or workflows.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 in the Record History section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved a general government funding/operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check74 days agoChange DetectedThe Record History page shows the same version list with dates; minor visual/layout changes are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.